Skip to content
  • Clinical Studies
  • Pharma GMP
  • Pharma Tips
  • Stability Studies
  • Pharma Books
  • Schedule M

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • SOP – Blog Post
  • Toggle search form

API Manufacturing: SOP for Disposal of Rejected or Contaminated Materials – V 2.0

Posted on By

API Manufacturing: SOP for Disposal of Rejected or Contaminated Materials – V 2.0

Standard Operating Procedure for Disposal of Rejected or Contaminated Materials in API Manufacturing

Department API Manufacturing
SOP No. SOP/API/017/2025
Supersedes SOP/API/017/2022
Page No. Page 1 of 11
Issue Date 13/04/2025
Effective Date 15/04/2025
Review Date 13/04/2026

1. Purpose

To establish a standardized procedure for the safe, secure, and compliant disposal of rejected or contaminated raw materials, intermediates, and final APIs to prevent accidental use or environmental harm.

2. Scope

This SOP applies to all rejected and/or contaminated materials—raw, in-process, or finished—identified in the warehouse or production areas of the API manufacturing unit.

3. Responsibilities

  • Warehouse/Production Personnel: Identify and segregate rejected or contaminated materials.
  • QA Officer: Evaluate material status, authorize disposal, and verify disposal documentation.
  • EHS Officer: Ensure safe disposal as per environmental and regulatory guidelines.
See also  API Manufacturing: SOP for Issuance of Raw Materials to Production - V 2.0

4. Accountability

The QA Head and EHS Manager are jointly accountable for verifying that rejected or contaminated materials are safely and irreversibly disposed of with appropriate documentation.

5. Procedure

5.1 Identification of Rejected/Contaminated Materials

  1. Materials may be considered for disposal due to:
    • OOS (Out of Specification) test results
    • Label mix-up or misidentification
    • Microbial/chemical contamination
    • Physical damage (e.g., torn packaging, leakage)
    • Expired or re-test failed materials
  2. Label such items as “REJECTED – DO NOT USE” with red-colored tags.
  3. Record material details in the “Rejected Material Register” (Annexure-1).

5.2 Segregation and Quarantine

  1. Transfer materials to a designated “Rejected Material Area” secured with restricted access.
  2. Do not allow rejected items to remain in general storage or dispensing areas.
  3. Keep them physically separated by type (solids/liquids/flammables) in labeled bins or pallets.

5.3 Evaluation and Disposal Authorization

  1. Prepare a “Material Disposal Request Form” (Annexure-2) with:
    • Material type and batch number
    • Reason for rejection
    • Quantity to be disposed
  2. QA will evaluate the request and approve or reject disposal based on investigation outcome.
See also  API Manufacturing: SOP for Pest Control and Monitoring Program - V 2.0

5.4 Disposal Methods

  1. Disposal shall be done in presence of QA & EHS personnel via:
    • Incineration (flammables, toxic chemicals)
    • Neutralization followed by drainage (as per MSDS)
    • Secure landfill (solids, non-toxic material)
    • Return to vendor (where applicable)
  2. Use approved third-party waste management agencies if required and retain certificates.

5.5 Documentation and Record-Keeping

  1. Maintain “Disposal Record Log” (Annexure-3) signed by all involved parties.
  2. Retain the following:
    • Disposal request
    • Investigation report
    • Disposal certificate (if external agency used)

6. Abbreviations

  • SOP: Standard Operating Procedure
  • QA: Quality Assurance
  • EHS: Environment, Health & Safety
  • OOS: Out of Specification
  • MSDS: Material Safety Data Sheet

7. Documents

  1. Rejected Material Register (Annexure-1)
  2. Material Disposal Request Form (Annexure-2)
  3. Disposal Record Log (Annexure-3)

8. References

  • ICH Q7 – GMP for Active Pharmaceutical Ingredients
  • 21 CFR Part 211.192 – Production Record Review
  • WHO TRS 957 Annex 5 – Disposal of Waste in Pharmaceutical Facilities
See also  API Manufacturing: SOP for Labeling of Raw Materials with Status Tags - V 2.0

9. SOP Version

Version: 2.0

10. Approval Section

Prepared By Checked By Approved By
Signature
Date
Name
Designation
Department

11. Annexures

Annexure-1: Rejected Material Register

Date Material Batch No. Reason for Rejection Qty Entered By
13/04/2025 Sodium Hydroxide SH202504 Contaminated 10 kg

Annexure-2: Material Disposal Request Form

Material Batch No. Reason Qty Requested By Approved By (QA)
Sodium Hydroxide SH202504 Moisture contamination 10 kg

Annexure-3: Disposal Record Log

Date Material Batch Method Qty Disposal Done By Verified By (QA)
14/04/2025 Sodium Hydroxide SH202504 Neutralization 10 kg

Revision History:

Revision Date Revision No. Revision Details Reason for Revision Approved By
01/01/2022 1.0 Initial Release GMP Requirement QA Head
13/04/2025 2.0 Expanded Disposal Categories and Record Requirements Audit Recommendation QA Head
API Manufacturing V 2.0 Tags:API batch record, API BMR, API calibration, API centrifuge, API cleaning, API crystallization, API deviation, API documentation, API drying, API equipment cleaning, API filtration, API GMP compliance, API granulation, API hold time, API impurities, API line clearance, API manufacturing, API process, API quality control, API reactor, API sampling, API solvent handling, API validation, API waste disposal, API yield

Post navigation

Previous Post: Tablets: SOP for QA Involvement in Tablet Packaging Line Validation – V 2.0
Next Post: BA-BE Studies: SOP for Project Risk Identification and Mitigation – V 2.0

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version